ライフサイエンスコーパス: PKC

1 PKC (protein kinase C) was induced by retinoic acid, and

2 PKC is known to potentiate TRPV1 activity during activat

3 PKC mediates many diabetic complications, and PKCalpha a

4 in chRCC and identifies the PLCG2/IP3/Ca(2+)/PKC axis as a potential therapeutic target in patients w

5 Compared with U50,488H, PKC activation promoted much higher S356/T357 phosphoryl

6 The cortical polarity regulators PAR-6, PKC-3, and PAR-3 are essential for the polarization of a

7 in kinase C in an ALK-dependent manner and a PKC inhibitor blocked dopamine D2 receptor internalizati

8 which was not previously considered to be a PKC site.

9 deficiency increases activity of PKCzeta, a PKC isoform controlling cell polarity, and that addition

10 ocytes and stimulated vasoconstriction via a PKC-dependent mechanism that required Rab11A S177.

11 ild-type phenotype, similar to rescue with a PKC construct.

12 s sn-1,3 DAG, which is known not to activate PKC, and insulin signaling was intact.

13 2-myristate 13-acetate transiently activated PKC and HDAC5, and upregulated MEF2c expression.

14 al pathways for beta(2) integrin activation (PKC, PI3K, and PLC) were similarly activated in both T c

15 ity can enhance the robustness of DAG/active PKC polarization with respect to chemoattractant concent

16 In addition, PKC activation by phorbol ester induced agonist-independ

17 Although PKC- is dispensable for TCR-independent Treg proliferati

18 2)-isoprostanes, NOX2 (NADPH oxidase 2), and PKC (protein kinase C) were measured in obese mice and c

19 EGF stimulation also elicited a Ca(2+)- and PKC-dependent reduction in synaptojanin1 recruitment to

20 PAR-6 and PKC-3 are required in the epidermal epithelium for anima

21 protein degradation, we show that PAR-6 and PKC-3, but not PAR-3, are essential for postembryonic de

22 kinase C) was induced by retinoic acid, and PKC inhibition also rescued the abnormal phenotypes in t

23 demonstrated that INPP4B suppresses Akt and PKC signaling pathways and modulates AR transcriptional

24 and the oncogenic signaling pathways Akt and PKC.

25 diators, and increased TRPC6, PKC-alpha, and PKC-beta expression.

26 ), which enable two example kinases-AMPK and PKC-to phosphorylate target proteins that are not otherw

27 n-coupled receptor endothelin receptor B and PKC epsilon, regulates the number of myelin sheaths form

28 ose condition; the crosstalk between DAG and PKC regulates the span of anabolic bistable region with

29 ndent decreases in actin network density and PKC-dependent increases in point contact density.

30 Furthermore, levels of AT1 receptor mRNA and PKC-mediated NMDAR phosphorylation in the PVN were signi

31 nt (I(Kur)) and F(2)-isoprostanes, NOX2, and PKC-alpha/delta expression and atrial fibrosis were sign

32 and varepsilon-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, poss

33 ing in animals, including the ERK, PI3K, and PKC pathways.

34 or pertussis toxin and inhibitors of PKA and PKC had no effect on EP2- and BK2-mediated inhibition of

35 tonic current, which was blocked by PKA and PKC inhibition.

36 aptic plasticity describing CaMKII, PKA, and PKC pathways and their contribution to synaptic potentia

37 osphorylation by the protein kinases PKG and PKC inhibits NKA activity, whereas dephosphorylation by

38 e activity of SFKs, Syk, Btk, PLCgamma2, and PKC.

39 Simultaneous inhibition of Syk and PKC revealed additive dilatory effects, whereas combined

40 on calcium-induced de novo transcription and PKC-dependent mRNA stabilization.

41 e influence of another polarity kinase, aPKC/PKC-3.

42 mediators activate protein kinases (such as PKC) that phosphorylate TRPV1 and thereby enhance its fu

43 tment, increases of VEGF and PlGF as well as PKC activity were detected in hRECs.

44 the recruitment of the Par-3:Par-6:atypical PKC protein complex, a critical regulator of cell polari

45 kinases Stk39 (SPAK) and Prkci (an atypical PKC) are consistent with PKA-independent regulation of t

46 ic compound designed to inhibit the atypical PKC, PKMzeta, a protein implicated in learning and memor

47 ibitor (Go6983) or an inhibitor for atypical PKCs (CRT0066854).

48 the unique neuronal intrinsic signaling axis PKC-STAT3-NADPH oxidase 2 (NOX2), enhancing redox signal

49 EF by PKC to be the mechanistic link between PKC and RhoA.

50 Depletion of INF2 disrupts both PKC beta II translocation and Lats1/2 activation.

51 that the DAT N terminus is required for both PKC-mediated DAT-Rit2 dissociation and DAT internalizati

52 reas modulation of suppressive activities by PKC-theta and Dlgh1 signaling pathways are shared.

53 also its activation in the axonal bouton by PKC-induced calcium-dependent phosphorylation at Ser-41

54 88A) alone, a response no longer enhanced by PKC inhibition.

55 list of therapeutic indications exhibited by PKC modulators.

56 d a Hebbian form of LTP that was mimicked by PKC activation.

57 unctions in parallel with phosphorylation by PKC-3 to suppress PAR-1 activity in the anterior cytopla

58 port that myosin II activity is regulated by PKC during 5-HT responses and that PKC activity is neces

59 sphorylation of serine 240 on p115 RhoGEF by PKC to be the mechanistic link between PKC and RhoA.

60 Prephosphorylation of Nem1-Spo7 by PKC inhibits the PKA phosphorylation of Nem1, whereas pr

61 ses, including protein kinase A (PKA) and C (PKC).

62 ic trafficking, and direct protein kinase C (PKC) activation acutely diminishes DAT surface expressio

63 tress and hERG function is protein kinase C (PKC) activation; however, seemingly conflicting results

64 TRESK is activated by the protein kinase C (PKC) activator PMA (phorbol 12-myristate 13-acetate) in

65 er endogenous AT1 receptor-protein kinase C (PKC) activity mediates the augmented NMDAR activity of P

66 TRPC1-based SOCs requires protein kinase C (PKC) activity, which is proposed to phosphorylate TRPC1

67 TRPC1-based SOCs requires protein kinase C (PKC) activity, with store-operated PKC-dependent phospho

68 phospholipase C (PLC)beta1/protein kinase C (PKC) activity.

69 s a Galpha(i/o)-Gbetagamma-protein kinase C (PKC) alpha phosphorylation pathway that limits MOR distr

70 and endosomal signaling by protein kinase C (PKC) and extracellular signal-regulated kinase (ERK) pat

71 egulated by members of the protein kinase C (PKC) and GPCR kinase (GRK) families, although the relati

72 nowledge on the biology of protein kinase C (PKC) and its involvement in disease, limited success has

73 atase 1 (Phlpp1) regulates protein kinase C (PKC) and other proteins in the control of bone mass.

74 or, phospholipase C (PLC), protein kinase C (PKC) and phosphoinositide-3-kinase (PI3K), and subsequen

75 ermore, we identified that protein kinase C (PKC) beta II is a major mediator of Ca(2+)-induced Lats1

76 de stimulation by Galphas, protein kinase C (PKC) betaII, or calcium-calmodulin kinase II (CaMKII) an

77 nstrate that activation of protein kinase C (PKC) by phorbol myristate acetate, Gq/11-coupled GPCR, o

78 gh various kinases such as protein kinase C (PKC) contribute to the expression of long-term plasticit

79 We demonstrated that Protein Kinase C (PKC) epsilon is selectively expressed by platelets from

80 unexpected features of the protein kinase C (PKC) family of serine/threonine protein kinases.

81 endocytosis and activated protein kinase C (PKC) in the cytosol and extracellular signal regulated k

82 Spinal protein kinase C (PKC) inhibition with Go6983 or PKCdelta peptide inhibito

83 hibit remarkably different protein kinase C (PKC) isoform affinities.

84 e that classical and novel protein kinase C (PKC) isoforms distinctly regulate cardiac fibroblast tra

85 revious work suggests that protein kinase C (PKC) isoforms play a role in cardiac fibrosis and remode

86 Protein kinase C (PKC) isozymes function as tumor suppressors in increasin

87 G)/phorbol ester-regulated protein kinase C (PKC) isozymes have been widely linked to tumor promotion

88 We show that protein kinase C (PKC) lambda/iota loss in hepatocytes promotes autophagy

89 lase (HDAC) inhibitors and protein kinase C (PKC) modulators, provides a promising strategy to reduce

90 Protein kinase C (PKC) modulators-including prostratin, ingenol esters, br

91 trisphosphate (IP3)/Ca(2+)/protein kinase C (PKC) pathway significantly impaired the activation of en

92 the phospholipase C (PLC)/protein kinase C (PKC) pathway.

93 (PLC)beta1 activities and protein kinase C (PKC) phosphorylation, although it is unclear how store d

94 s and that AKAP79-anchored protein kinase C (PKC) primarily drives the appearance of these receptors

95 bition; however, augmented protein kinase C (PKC) signaling was found to contribute to the increased

96 o alanine mutations at the protein kinase C (PKC) site Cx43(S368A), the casein kinase 1 (CK1) sites C

97 as being important in the protein kinase C (PKC) supported activity of the GG genotype of GAL5.1 but

98 Protein kinase C (PKC) theta, a serine/threonine kinase, is involved in TH

99 ty for bryostatin's target protein kinase C (PKC) while enabling exploration of their divergent biolo

100 ignaling cascade that, via protein kinase C (PKC), activates in parallel the MAP-kinase and FAK/Yes-a

101 small GTPase 1 (RAC1) and protein kinase C (PKC), and a later arrestin-scaffolded phase, requiring R

102 ), protein kinase A (PKA), protein kinase C (PKC), and AMPA receptor genes that play a pivotal role i

103 KM), the truncated form of protein kinase C (PKC), can maintain long-term changes in synaptic strengt

104 ugh its phosphorylation by protein kinase C (PKC), which plays multiple roles, including the regulati

105 -syn fails to complex with protein kinase C (PKC), which, in turn, results in impaired activation of

106 he KCNMA1 gene, permitting protein kinase C (PKC)-dependent channel activation.

107 T1 receptor expression and protein kinase C (PKC)-mediated NMDA receptor phosphorylation levels in th

108 ed in vitro and in vivo by protein kinase C (PKC)-mediated phosphorylation at CaS(T888) However, PKC

109 protein kinase A (PKA) and protein kinase C (PKC).

110 P(2) hydrolysis, activates protein kinase C (PKC).

111 tion of kinases, including protein kinase C (PKC).

112 ation of NADPH oxidase and protein kinase C (PKC).

113 protein kinase A (PKA) and protein kinase C (PKC).

114 (MEF2c) expression via the protein kinase C (PKC)/histone deacetylase 5-mediated pathway.

115 vely specific activator of protein kinase C (PKC)epsilon, (also of PKCalpha) on impaired synaptic pla

116 Here we report that protein kinase C (PKC)lambda/iota is downregulated in de novo and during t

117 ublic databases identified protein kinase C (PKC)zeta as a TRIM32-associated protein that contributes

118 RhoA activity are dependent on p63 and Ca2+/PKC, respectively, and further identified phosphorylatio

119 ts suggest that, in addition to calcineurin, PKC regulates TRESK by changing the phosphorylation stat

120 ibitor Go6983 and the inhibitor of classical PKC isoforms Go6976, suggesting that classical PKCs regu

121 C isoforms Go6976, suggesting that classical PKCs regulate CF transdifferentiation.

122 novel isozymes (nPKCs) relative to classical PKCs (cPKCs).

123 ffect on Slack channels in which a conserved PKC phosphorylation site (S407) that regulates the curre

124 In contrast, PKC activation caused a lower level of agonist-independe

125 eover, the mechanisms by which Rit2 controls PKC-stimulated DAT endocytosis are unknown.

126 d product of PLC that activates conventional PKCs, is focally enriched at the up-gradient leading edg

127 hat thermotaxis is controlled by cooperative PKC-2-mediated signaling in both AFD sensory neurons and

128 elease from synaptic vesicles, is a critical PKC-2 effector in AFD.

129 CLR endocytosis and activation of cytosolic PKC and nuclear ERK, which derive from endosomal CLR.

130 through activation of mTOR via PLCgamma/DAG/PKC signaling, not via Akt/Rheb signaling.

131 regulation of beta-catenin levels and define PKC as an important beta-catenin interaction partner and

132 n to enhance protein kinase C isoform delta (PKC-delta) activity; this resulted in a recruitment of p

133 ultaneously, protein kinase C isoform delta (PKC-delta) was phosphorylated at threonine 505 by phosph

134 In conclusion, our results reveal distinct PKC-dependent regulation of CF transdifferentiation and

135 mediated adhesion was mediated by downstream PKC and Rho signaling.

136 Drugging PKC isoforms has offered much promise, but when and how

137 An apparently equivalent PKC regulatory site in metabotropic glutamate receptor 5

138 th K(i)'s < 5 nM, while the latter exhibited PKC affinities that were up to ~180-fold less potent.

139 and PDAC of Pdx1-Cre;Kras(G12D/+);p53(f/+) (PKC) mice as early as 2 mo, suggesting that GRP78 could

140 independently converge on DAT to facilitate PKC-stimulated DAT endocytosis.

141 t both subunits of the complex are bona fide PKC substrates.

142 gs, which per our design retain affinity for PKC but exhibit variable PKC translocation kinetics.

143 , it is unknown whether Rit2 is required for PKC-stimulated DAT endocytosis in DAergic terminals or w

144 Further, Rit2 was required for PKC-stimulated DAT internalization in both male and fema

145 Although CD4(+) T-cells from PKC-(-/-) mice were also defective in G-BMDC induced Tre

146 ases, for example Dopamine-PKA-CREB and GABA-PKC-CREB signaling pathways, the biotypes were oppositel

147 findings highlight the GNAQ/11 -> PLCbeta -> PKC -> MAPK pathway as the central signaling axis to be

148 te in over 5,000 patient tumors, with higher PKC levels correlating (1) inversely with PHLPP1 levels

149 Thus, influenza virus exploits host PKCs to regulate RNP assembly, a step required for the t

150 diated phosphorylation at CaS(T888) However, PKC inhibition enhances signaling even in CaSs lacking T

151 We identified PKC delta and varepsilon as required and sufficient to a

152 Therefore our findings identify PKC-theta as a critical factor for ILC2 activation that

153 On the other hand, a significant decrease in PKC activity, and inhibition of nuclear factor kappa B (

154 al unexpected region-specific differences in PKC-stimulated DAT trafficking in bona fide DAergic term

155 region- and/or sex-dependent differences in PKC-stimulated DAT trafficking.

156 Further, beta-catenin overexpression in PKC-deficient podocytes could restore the wild-type phen

157 nterventions, further prompts to incorporate PKC family actions and interventions in this ecosystem,

158 r the differential involvement of individual PKC isozymes in the control of gene expression, our stud

159 ng AT1 receptors with losartan or inhibiting PKC with chelerythrine significantly decreased the frequ

160 eness to arginine-vasopressin (an inhibitory PKC-dependent response).

161 Serine-875 represents the missing inhibitory PKC phosphorlyation site in CaS that in tandem with Thr-

162 that signaling abnormalities in the PLC/IP3/PKC/ERK pathway (phospholipase C/inositol 1,4,5-triphosp

163 rapid cell permeation and engagement of its PKC target.

164 ase (PKA), calcium-dependent protein kinase (PKC), and immune regulation.

165 Ser(315) is a known PKC-targeted site in flotillin-1.

166 Mice lacking PKC-theta had reduced ILC2 numbers, TH2 cell numbers and

167 The analogue with bryostatin-like PKC affinities also exhibited bryostatin-like PKC transl

168 KC affinities also exhibited bryostatin-like PKC translocation kinetics in vitro, indicating rapid ce

169 vent in vivo, we genetically altered a major PKC phosphorylation site, mouse TRPV1 S801, to alanine.

170 in Nem1 and Ser-22/Ser-28 in Spo7 are major PKC target sites of phosphorylation.

171 By mapping PKC phosphorylation sites on LB3 and testing the effects

172 greater insight into mechanisms that mediate PKC-regulated DAT internalization and reveal unexpected

173 have now identified CaS(S875) as the missing PKC phosphorylation site that, together with CaS(T888),

174 In AFD neurons, PKC-2 is a Ca(2+) sensor and signal amplifier that opera

175 After U50,488H treatment, GRKs, but not PKC, were involved in agonist-induced KOPR internalizati

176 , the present study examined whether a novel PKC isoform(s) is involved in activating TRPC1-based SOC

177 (CaMKII) and inhibition by Galphai/o, novel PKC isoforms, or calcium-calcineurin.

178 3 but not with Go6976, indicating that novel PKC isoforms (nPKCs) regulate CF proliferation.

179 iglyceride, 30% of diacylglycerol and 50% of PKC level in the heart, as well as ameliorating oxidativ

180 Ca(2+) induces accumulation of PKC beta II in an actin cytoskeletal compartment.

181 rement of DOPr endocytosis for activation of PKC at the plasma membrane and in the cytosol and ERK in

182 ld-type hERG channels, chronic activation of PKC by PMA (30 nM, 16 hours) increased both Delta2-354 h

183 nt (I(hERG)) and I(Kr) Chronic activation of PKC by PMA (30 nM, 16 hours) increased I(Kr) in cardiomy

184 Acute activation of PKC by PMA (30 nM, 30 minutes) reduced both hERG current

185 In agreement, heterologous activation of PKC by stimulating the chemokine receptor CXCR5 with its

186 The activation of PKC promotes the selective strengthening of alpha3-conta

187 esults demonstrate that direct activation of PKC via the phorbol ester phorbol 12-myristate 13-acetat

188 in-mediated currents after the activation of PKC was substantially impaired in sensory neurons from K

189 uced PIP(2) depletion, whereas activation of PKC with phorbol-12-myristate-13-acetate potentiated the

190 involving frequency-dependent activation of PKC(epsilon) (protein kinase C epsilon).

191 lity mainly through increasing activation of PKC-Erk1/2-NOS axis via VEGFR1, while HG-induced elevati

192 l TRPV1 in sensory neurons via activation of PKC.

193 Coexpression of PKC slowed recovery of the K(+) current to the resting s

194 dy is to define the relative contribution of PKC and GRK to CXCR4 signaling attenuation by studying t

195 10-R98S cells, in part via downregulation of PKC-theta, with no effect on RPL10-WT cells.

196 t, possibly explaining the limited effect of PKC inhibitors to durably suppress MAPK in UM.

197 e PKC isoforms eta and epsilon The effect of PKC is not mediated by calcineurin phosphatase, which is

198 We investigated the effects of PKC activation using phorbol 12-myristate 13-acetate (PM

199 PH+Sac/Val animals had altered expression of PKC isozymes in RV tissue compared with PH alone.

200 freading step that maintains the fidelity of PKC autoinhibition and reveals a prominent loss-of-funct

201 ccess has been attained in the generation of PKC isozyme-specific modulators acting via the C1 domain

202 ch are characteristics of the novel group of PKC isoforms (delta, epsilon, eta, theta).

203 considered to be activated independently of PKC.

204 Inhibition of PKC activity by Go 6976 prevented HG-induced increases o

205 However, inhibition of PKC activity does not alter CXCL12-mediated ubiquitinati

206 r-502 and Ser-800, indicating involvement of PKC.

207 PKCalpha is a conventional isoform of PKC and a well-known binding partner of beta-catenin, wh

208 , in this study, that PKCbeta, an isoform of PKC, is required for both Src and Pyk2 activation/phosph

209 er by suppressing the steady-state levels of PKC.

210 Cell-specific manipulation of PKC-2 activity revealed that thermotaxis is controlled b

211 ells markedly reduced the phosphorylation of PKC-delta and impeded the recruitment of p-PKC-delta and

212 More generally, selected prodrugs of PKC modulators avoid the bolus toxicities of the parent

213 of p32 in the activation and recruitment of PKC-delta to phosphorylate lamin A/C and facilitate porc

214 ipin1 deficiency leads to the suppression of PKC isoform activities, as well as inhibition of the dow

215 Attenuated membrane translocation of PKC(epsilon) appeared to be a likely molecular mechanism

216 PKMs, the constitutively active isoforms of PKCs generated by calpain cleavage, in the sensory neuro

217 kinase C (PKC) activity, with store-operated PKC-dependent phosphorylation of TRPC1 essential for cha

218 e report that the phosphatase PHLPP1 opposes PKC phosphorylation during maturation, leading to the de

219 found that elevation of cytosolic Ca(2+) or PKC beta II expression inhibits YAP/TAZ-mediated gene tr

220 and neo-phosphorylations of BRD4 by AMPK or PKC.

221 The GABAergic LTP is mimicked with PKA or PKC activation.

222 Blocking AT1 receptors or PKC activity normalizes the increased pre- and postsynap

223 y activated enzyme that acts much like other PKC isoforms to transduce growth factor-dependent signal

224 tion partner and signaling opponent of other PKC isoforms in podocytes.

225 f PKC-delta and impeded the recruitment of p-PKC-delta and Cap to the nuclear membrane, hence abolish

226 -kappaB activity, which was blocked by a pan PKC inhibitor (Go6983) or an inhibitor for atypical PKCs

227 Succinate increases phosphorylation of pan-PKC, especially the atypical PKCzeta level which was blo

228 The decreases were inhibited with the pan-PKC inhibitor Go6983 and the inhibitor of classical PKC

229 The partial PKC agonist isophthalate derivative bis(1-ethylpentyl) 5

230 The only known CNS-permeant PKC inhibitor is the selective estrogen receptor modulat

231 re-directed behaviors elicited by persistent PKC-2 activation or inhibition in AFD (or intestine) dis

232 The pharmacologic PKC-theta inhibitor (Compound 20) administered during al

233 Our results indicate that pharmacological PKC activation may be a promising strategy to inhibit my

234 resulted in a recruitment of phosphorylated PKC-delta to the nuclear membrane, which further phospho

235 oned as an adaptor to recruit phosphorylated PKC-delta and Cap to the nuclear membrane to phosphoryla

236 tely regulated by transient phosphorylation, PKC is constitutively phosphorylated following biosynthe

237 on via glucose-responsive kinases GSK3, PKA, PKC, and CDK5.

238 Inhibition of PLCgamma/PKC-induced mTOR activation impairs IL-7-mediated B cell

239 A 48-hour exposure to the potent PKC activator phorbol 12-myristate 13-acetate (PMA) at 1

240 Similar to CXCL12, PMA promotes PKC-dependent phosphorylation of serine residues within

241 ylation of the downstream signaling protein, PKC-alpha, and Ca(2+)/calmodulin-dependent protein kinas

242 Inhibition of AT1 receptor-PKC activity in the hypothalamus reduces arterial blood

243 indings suggest that endogenous AT1 receptor-PKC activity is essential for presynaptic and postsynapt

244 ver, seemingly conflicting results regarding PKC regulation of hERG have been reported.

245 ealed that PKCepsilon or other DAG-regulated PKCs (PKCalpha and PKCdelta) were dispensable for the ac

246 ligands capable of differentially regulating PKC isozyme-specific function in cellular models.

247 Here we investigated the effects of selected PKC agonists and inhibitors on cardiac fibroblast (CF) p

248 Selective PKC inhibition may therefore be a useful therapeutic too

249 hyperglycaemia can be reversed by selective PKC inhibition.

250 exhibited bryostatin-like binding to several PKC isoforms with K(i)'s < 5 nM, while the latter exhibi

251 Taken together, our study shows PKC/NOX-mediated ROS generation and PARP-1 activation as

252 immunoblotting with a phosphoserine-specific PKC substrate antibody, revealed that Ser-201 in Nem1 an

253 r Ser(322), disrupt thermotaxis and suppress PKC-2-dependent cryophilic migration.

254 Moreover, the potential of targeting PKC with pharmacological tools to inhibit pathologic fib

255 ulated by PKC during 5-HT responses and that PKC activity is necessary for increases in traction forc

256 cells, able to mediate Ca(2+) entry but that PKC was also involved in both Ca(2+) entry and PS exposu

257 We conclude that PKC regulates hERG in a balanced manner, increasing expr

258 Previous cell line studies demonstrated that PKC-stimulated DAT endocytosis requires both Ack1 inacti

259 ibition in AFD (or intestine) disclosed that PKC-2 regulates initiation and duration of cryophilic dr

260 Ex vivo studies revealed that PKC activation acutely decreased DAT surface expression

261 pulldown studies in cell lines revealed that PKC activation drives DAT-Rit2 surface dissociation and

262 a1 and Col3a1 nPKC-dependently, showing that PKC activation attenuates matrix synthesis in CFs.

263 Collectively, our data strongly suggest that PKC activation by stolonidiol is responsible for the res

264 entiation and proliferation and suggest that PKC agonists exhibit potential as an antifibrotic treatm

265 Overall, these results suggest that PKC and GRK6 contribute to unique aspects of CXCR4 phosp

266 These results suggest that PKC-mediated phosphorylation of TRPV1 S801 contributes t

267 The PKC-dependent dephosphorylation of TRESK protein was als

268 se construct (MARK2Delta) also abolished the PKC-dependent TRESK activation.

269 In contrast, the PKC pancreata bearing a Grp78(f/+) allele (PKC78(f/+) mi

270 n kinase C (aPKC) isozymes are unique in the PKC superfamily in that they are not regulated by the li

271 the phosphatase complex by PKA inhibits the PKC phosphorylation of Spo7.

272 efore, the likely mechanism of action is the PKC-dependent inhibition of the kinase responsible for t

273 PKCepsilon, an oncogenic member of the PKC family, is abnormally overexpressed in lung cancer a

274 We investigated the identity of the PKC isoform involved in activating TRPC1-based SOCs in r

275 in crd1Delta cells, and up-regulation of the PKC pathway by expression of the PKC1(R398P) gene, which

276 o activate TRPC1-based SOCs suggest that the PKC isoform involved requires diacylglycerol (DAG) but i

277 utant Nem1-Spo7 complexes indicates that the PKC phosphorylation of Nem1 exerts a stimulatory effect,

278 pharmacological inhibition, we show that the PKC/RasGRP3/MAPK signaling branch is the essential compo

279 study, we investigated the mechanism of this PKC-dependent TRESK regulation.

280 Supporting this, PKC-dependent Cx43 S368 phosphorylation, which signals C

281 Zebrafish studies indicated three PKC-specific phosphorylation sites in beta-catenin that

282 rmore, we found that beta-arrestin2 binds to PKC-phosphorylated AT1R in a distinct active conformatio

283 rotein ORP3, and that Ca(2+) influx triggers PKC-dependent translocation of this complex to ER/plasma

284 inflammatory mediators, and increased TRPC6, PKC-alpha, and PKC-beta expression.

285 Two PKC inhibitors were also tested, chelerytherine chloride

286 GK inhibition was eliminated by mutating two PKC-targeted phosphorylation sites, Ser-502 and Ser-800,

287 The two PKC orthologs Pck1 and Pck2 in the fission yeast Schizos

288 activated by coexpression of the novel-type PKC isoforms eta and epsilon The effect of PKC is not me

289 In summary, the activation of novel-type PKC results in the slow (indirect) dephosphorylation of

290 By precisely removing a unique PKC phosphorylation site (TRPV1 S801) in mice through CR

291 retain affinity for PKC but exhibit variable PKC translocation kinetics.

292 mainly suppressed phosphorylation of VEGFR1, PKC, and Erk1/2, as well as NOS1 expressions and hyperpe

293 RasGRP3 activation occurs via PKC delta- and varepsilon-dependent phosphorylation and

294 ctivity and elevated sympathetic outflow via PKC in hypertension.

295 In vivo PKC beta II expression inhibits GBM tumor growth and pro

296 Interestingly, when PKC activity was up-regulated, 5-HT treatments resulted

297 5 increases its affinity for PIP(2), whereas PKC-dependent phosphorylation of the Kv7.5 carboxy termi

298 increase in hERG protein was associated with PKC-induced phosphorylation (inhibition) of Nedd4-2, an

299 Compared with PKC, the PKC78(f/+) pancreata showed substantial reducti

300 ide 3-kinase (PI3-K), protein kinase C-zeta (PKC-zeta), extracellular signal-regulated kinase 1/2 (ER